| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |